Diagnostyka S.A. (WSE:DIA)
175.60
-0.10 (-0.06%)
Last updated: Jul 22, 2026, 10:25 AM CET
Diagnostyka Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Diagnostyka stock has a consensus rating of "Buy" and an average price target of zł 204.28. The average 1-year stock price forecast is 16.33% higher than the current stock price, while the lowest is zł 176.00 (+0.23%) and the highest is zł 217.00 (+23.58%).
Price Target: zł 204.28 (+16.33%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Diagnostyka stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains zł 188.00 → zł 176.00 | Hold | Maintains | zł 188.00 → zł 176.00 | +0.23% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
2.73B
from 2.42B
Increased by 12.54%
Revenue Next Year
3.09B
from 2.73B
Increased by 13.12%
EPS This Year
8.03
from 7.50
Increased by 7.14%
EPS Next Year
10.21
from 8.03
Increased by 27.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.